HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea
· Delayed Price · Currency is KRW 21,250
-750 (-3.41%)
Mar 28, 2025, 3:30 PM KST
-42.80% (1Y)
| Market Cap | 298.40B |
| Revenue (ttm) | 36.10B |
| Net Income (ttm) | 472.66M |
| Shares Out | 14.04M |
| EPS (ttm) | 34.13 |
| PE Ratio | 631.32 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 554,474 |
| Average Volume | 1,308,885 |
| Open | 22,550 |
| Previous Close | 22,000 |
| Day's Range | 21,050 - 22,550 |
| 52-Week Range | 15,150 - 37,250 |
| Beta | 0.35 |
| RSI | 40.18 |
| Earnings Date | n/a |